Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

NICE agrees approval deal for ultra-rare juvenile bone disease

July 5, 2017 Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …
News
8384110298_da510e0347_c

Google’s DeepMind app deal with NHS brought into question

July 5, 2017 Medical Communications, Research and Development Alphabet, DeepMind, NHS, google

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …
News
shutterstock_159488225

Tumour genome mapping could lead to improved outcomes, research finds

July 5, 2017 Research and Development Cancer, Hi-C

A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …
News
new_wave_logo_cmyk

Gain insight into what your peers are doing

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
Feature
shutterstock_38078521

Researchers boost existing antibiotic to tackle drug resistance

July 4, 2017 Research and Development University of Lincoln, antibiotic resistance

The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …
News
shutterstock_146497481

Top CMO pushes for routine genome screening on NHS

July 4, 2017 Manufacturing and Production, Research and Development NHS, genome sequencing

England’s top Chief Medical Officer has called for routine DNA testing to become standard on the NHS in a bid …
News

Forging a path forward in neurological disorders

July 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …
Feature
index_ph001

Big success and even bigger failure for Daiichi Sankyo’s experimental therapy

July 3, 2017 Research and Development, Sales and Marketing Daiichi Sankyo, mirogabalin

Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success …
News
gsk_boronia_australia

GSK signs $43 million AI-based drug discovery deal with Exscientia

July 3, 2017 Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK

With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …
News
veeva_webinar

Free Webinar: How will quality management change by 2025?

July 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Webinar, veeva

Following on from the success of our previous free webinar sessions, Pharmafocus is partnering
News

Pricing Consultant Job Profile and Description

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Pricing Consultant Job Profile and Description About Global Pricing Innovations (GPI)
Appointment

Head of Product Innovation Job Profile and Description

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Head of Product Innovation Job Profile and Description About Global Pricing Innovations (GPI)
Appointment

Development Manager Job Profile and Description

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Development Manager Job Profile and DescriptionGPI is a global pricing consultancy launching products, services and offerings that make a measurable …
Appointment

ABPI reveals 10% increase in HCP payment disclosure

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, disclosure, disclosure uk

The headline news from the ABPI’s press conference on Disclosure UK was that healthcare professionals’ (HCPs) disclosure of payments for …
News

Eli Lilly arthritis drug outperforms Humira and receives NICE backing

June 30, 2017 Medical Communications, Research and Development, Sales and Marketing Eli Lilly, NICE, Olumiant, rheumatoid arthritis

Eli Lilly’s rheumatoid arthritis (RA) drug Olumiant (baricitinib) has been deemed cost-effective by NICE and has been recommended to be …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026